Life Science Construction Picks Up in 2Q
At the end of 2024, construction starts for life science projects had slowed to the lowest point since the onset of the pandemic, with less than 1 million square feet …
About Hilda Martin
Oversupply Presents Opportunity for Established Pharma
With many state-of-the-art, brand-new research facilities sitting empty across major research clusters in the U.S., established pharmaceutical and biotechnology firms have an opportunity to secure ideal spaces in prime locations. …
New Deliveries, Older Properties Most Impacted by Oversupply
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
Life Science Deliveries Stall in 1Q, Pipeline Still Significant
After a record year of Life Science construction in 2024, early 2025 brings a much needed stall in new project deliveries. In 2024, 22.8 million square feet of Life Science …
Established Micro Clusters More Insulated from Market Cycles
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …
4Q Life Science Inventory Reaches 400 Million Square Feet
The Life Science real estate sector is closing out 2024 with a total of 21.2M square feet of project completions, pushing sector inventory over 400M square feet. This represents an …
Life Science Occupancy Flattens in 3Q
The spotlight continues to be on the Life Science real estate sector as the industry works to absorb the significant amount of new inventory coming online. Nationwide, 23 million square …
Life Science Cluster Performance Varies Widely
Revista tracks life science properties across the entire U.S. and virtually every area has felt an impact from reduced space demand combined with overbuilding. That being said, not every life …
Market Spotlight: Raleigh/Durham
The Research Triangle has long been established as a strong biotech market, referred to as such due to the dense research and technology presence in the triangle created by UNC, …
RevistaLab Market Update Webcast – Listen to the Replay
Revista recently hosted a webcast discussing the latest data and insights for the Life Science Real Estate industry as of 1Q24. Hilda Martin and Stephen Lindsey reviewed details on supply/demand, …
Beyond the Big Three – What are the Largest Life Science Clusters?
Outside of the core three clusters – Boston, San Francisco and San Diego – what are the largest markets? How are they holding up with all the new recent supply …
Life Science Construction Grinds to Halt – Less than 1M SF Started in 1Q24
Construction starts slowed in 2023 as funding levels came down and demand for Life Science space softened, but 2024 has begun with almost a complete halt in new construction activity. …
Construction Pipeline Pushes U.S. Life Science Inventory to 440 Million Square Feet
Revista research has been hard at work putting together the most comprehensive database of Life Science properties available. Currently, open inventory stands at just over 359 million SF with another …
San Francisco Shows Resilience in 2023
Many metros are struggling this year to absorb new Life Science inventory as funding has significantly scaled back and companies become more cautious on space needs. After struggling to absorb …
See the Top Ten Boston Life Science Developers
Boston is the center of the US Life Science universe, and it has been even more of a focal point for the investment community in the past few years. Not …
Curious to Learn more about RevistaLab? Come join us for the launch next week!
Revista will officially be launching the first dedicated data service for Life Science real estate next week at our event in Boston. The Revista team has been hard at work …
Who Owns Life Science Real Estate?
Over the past few years, a spotlight has been on the Life Science industry (and the real estate that serves it) due to the pandemic and the rush to create …
Life Science Real Estate Inventory Growth – Are We Meeting Demand?
Unprecedented levels of funding into biotech and pharmaceutical companies in recent years has created explosive growth in the sector. That growth eventually translates into the need for more space. Are …